000 01509 a2200421 4500
005 20250511233749.0
264 0 _c19900426
008 199004s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-199004000-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIngle, J N
245 0 0 _aEvaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposure.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cApr 1990
300 _a93-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDihydrotestosterone
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHormones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aRemission Induction
700 1 _aKrook, J E
700 1 _aSchaid, D J
700 1 _aEverson, L K
700 1 _aMailliard, J A
700 1 _aLong, H J
700 1 _aMcCormack, G W
773 0 _tAmerican journal of clinical oncology
_gvol. 13
_gno. 2
_gp. 93-7
856 4 0 _uhttps://doi.org/10.1097/00000421-199004000-00001
_zAvailable from publisher's website
999 _c2322565
_d2322565